Key stats
About VANECK GENOMICS N HEALTHCA INN UCITS ETF
Expense ratio
0.35%
Home page
Inception date
Sep 2, 2022
ISIN
IE000B9PQW54
The Funds investment objective is to replicate the price and the performance, before fees and expenses, of an index that provides exposure to the performance of a representative portfolio of companies involved in the genomic healthcare and electronic healthcare industries
Classification
What's in the fund
Exposure type
Health Technology
Technology Services
Stock breakdown by region